Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Clinical Labs in South Africa Look to Integration and Consolidation - NHLS laboratories in South Africa consist predominantly of stand-alone automated systems. IT support in the majority of these laboratories is poor and constrains the use of certain equipment
Clinical Labs in South Africa Look to Integration and Consolidation

 

PRZOOM - /newswire/ - Cape Town, South Africa, 2008/07/15 - NHLS laboratories in South Africa consist predominantly of stand-alone automated systems. IT support in the majority of these laboratories is poor and constrains the use of certain equipment.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In addition, 250 nationwide laboratories are allowed public access to clinical services, especially CD4 monitoring for HIV/AIDS patients using anti retrovirals (ARVs).

Private laboratories such as Pathcare, Ampath and Lancet are currently incorporating integrated systems and implementing consolidated workstations. This trend is decreasing the number of analysers and labour required to operate these systems, subsequently reducing the operating costs.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), South African Clinical Laboratory Products Markets, finds that the markets earned revenues of $83.9 million in 2007 and estimates this to reach $111.2 million by 2013.

"Integrated systems and the consolidation of workstations are in an infancy stage and this trend will drive long-term market growth," notes Frost & Sullivan Research Analyst Lizelle Wentzel. "However, since integrated systems will reduce operational costs significantly, growth in the long term will decrease."

Future growth will depend greatly on the expansion of current laboratories and the establishment of new ones, provided patient volumes rise. The replacement of current systems and the incorporation of new systems are other areas that will increase growth.

Medical health insurance schemes in South Africa do not reimburse patients completely for all clinical diagnostic tests performed by private laboratories. Certain tests are not reimbursed at all, leaving the patient with the total cost at hand. Decreasing operating costs in order to lower costs to the patient is therefore essential for service providers.

"To remain competitive, manufacturers have focused their attention on improvements to instrumentation, including enhancements in automation throughput and ease of use," comments Wentzel. "New analysers provide expanded menus and add value to laboratory operations by minimising maintenance requirements, which is a critical factor in light of the widespread shortage of skilled technical personnel. By providing increasingly efficient, accurate, and simplified processes, manufacturers are creating solutions that help clinical laboratories boost productivity and lower costs."

The trend towards system consolidation and the development of higher volume instruments with increased throughput will result in a reduction of the total number of placements, since fewer analysers are becoming necessary to handle laboratory needs.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the South African clinical laboratory products markets, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

South African Clinical Laboratory Products Markets is part of the Drug Discovery Technologies & Clinical Diagnostics Growth Partnership Services Programme. All research included in this subscription provides detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

South African Clinical Laboratory Products Markets - M22B

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Clinical Labs in South Africa Look to Integration and Consolidation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Patrick Cairns 
+27 18 468 2315 patrick.cairns[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today